Combination of Chemoembolization plus Radiofrequency Ablation May Provide Better Survival Outcomes than Monotherapy for HCC
- PMID: 33778677
- PMCID: PMC7983659
- DOI: 10.1148/rycan.2019194005
Combination of Chemoembolization plus Radiofrequency Ablation May Provide Better Survival Outcomes than Monotherapy for HCC
Comment on
-
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.Sci Adv. 2019 Jul 3;5(7):eaaw5096. doi: 10.1126/sciadv.aaw5096. eCollection 2019 Jul. Sci Adv. 2019. PMID: 31281894 Free PMC article.
References
-
- Chu HH, Kim JH, Yoon H, et al. . Chemoembolization combined with radiofrequency ablation for medium-sized hepatocellular carcinoma: a propensity-score analysis. J Vasc Interv Radiol 2019. (in press). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
